surmount-1 tirzepatide trial obesity without diabetes Presented at #ECO2025: In the SURMOUNT-5 phase 3b involving adults with type 2 diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial results For the first time, tirzepatide
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6







:max_bytes(150000):strip_icc()/GettyImages-607034539-571644da3df78c3fa2ac4539.jpg)


















